The key to taking levothyroxine and metformin together is separating them by timing, not avoiding the combination. Levothyroxine needs an empty stomach; metformin works best with food. That built-in difference makes spacing the two drugs straightforward in practice, though the interaction between them is more interesting than most people realize. Metformin can actually shift your thyroid lab numbers, which has real implications for how your dose gets managed over time.
Why Levothyroxine Needs an Empty Stomach
Levothyroxine is famously finicky about absorption. Food, coffee, supplements, and other medications can all interfere with how much of the drug actually reaches your bloodstream. The standard guidance is to take it on an empty stomach, typically first thing in the morning, and wait at least 30 minutes before eating or drinking anything other than water. In a crossover trial testing morning versus bedtime dosing, patients were instructed to take their morning dose half an hour before breakfast on an empty stomach.1JAMA Internal Medicine. Effects of Evening vs Morning Levothyroxine Intake: A Randomized Double-blind Crossover Trial This fasting window is not just a suggestion. Research has shown that when you shift levothyroxine away from fasting conditions, your TSH can drift upward and your thyroid hormone levels can drop, meaning you absorb less of the drug.2PubMed Central. Dose administration time from before breakfast to before dinner affect thyroid hormone levels?
The reason fasting matters so much is that levothyroxine absorption happens primarily in the upper small intestine, and anything else in the stomach competes with it or changes the local pH enough to reduce uptake. If you want the tightest possible control of your thyroid levels and the narrowest fluctuation in your TSH, fasting ingestion is the way to achieve that.3The Journal of Clinical Endocrinology & Metabolism. Timing of Levothyroxine Administration Affects Serum Thyrotropin Concentration Some people do take levothyroxine at bedtime instead, and studies have found this can work, but the results are less predictable from person to person. If your routine already involves a morning dose, the simplest approach is to stick with it.
Why Metformin Goes With Food
Metformin sits on the opposite end of the timing spectrum. Its most common side effects are gastrointestinal: nausea, bloating, diarrhea, and stomach cramps, especially when you first start taking it. Taking metformin with meals significantly reduces these problems.4Clinical Therapeutics. Metformin: a new oral biguanide Most people take it with breakfast, lunch, or dinner depending on their prescribed frequency. Starting at a low dose and gradually increasing it also helps your gut adjust, but the with-food rule stays important throughout treatment.
This is where the natural separation between the two drugs becomes clear. Levothyroxine goes on an empty stomach first thing in the morning. You wait at least 30 minutes, then eat breakfast. Metformin goes with that breakfast (or with a later meal). The two drugs never need to be in your stomach at the same time, and no special maneuvering is required beyond following each drug’s existing guidelines.
A Practical Timing Routine
If you take levothyroxine once daily and metformin once or twice daily, a typical day looks like this: wake up, take levothyroxine with a full glass of water on an empty stomach, wait 30 to 60 minutes, eat breakfast, and take metformin with that meal. If you take metformin with dinner as well, the evening dose needs no special coordination with levothyroxine at all since that was absorbed hours ago.
People who take extended-release metformin usually take it once daily with their evening meal. In that case, the morning levothyroxine dose and the evening metformin dose are separated by most of the day, which is more than enough. Even if you take immediate-release metformin three times a day with meals, the first dose at breakfast still falls comfortably after the levothyroxine absorption window.
The one scenario that requires extra thought is if you prefer bedtime levothyroxine. In that case, you would need to ensure you have not eaten for two to three hours before taking it, which means your evening metformin dose with dinner should be early enough to allow a gap. For most people, a dinner at 6 or 7 p.m. and a bedtime levothyroxine dose at 10 p.m. works, but this schedule is more fragile. Late snacking or a delayed dinner can push things too close together.
How Metformin Pushes Your TSH Down
Here is where the combination gets genuinely interesting. Metformin does not just coexist with levothyroxine; it appears to actively change your thyroid numbers. A meta-analysis pooling data from five studies found that metformin significantly lowered TSH levels in people with hypothyroidism who were already on levothyroxine.5Scientific Reports. The effect of metformin therapy on serum thyrotropin and free thyroxine concentrations in patients with type 2 diabetes: a meta-analysis A separate study of obese diabetic women with hypothyroidism found that after three months on metformin, their average TSH dropped from about 3.1 to about 1.2, a substantial decrease. When metformin was stopped, TSH climbed back up.6Springer Link / Endocrine. Metformin reduces thyrotropin levels in obese, diabetic women with primary hypothyroidism on thyroxine replacement therapy
This effect is not limited to people on levothyroxine. In diabetic patients not taking any thyroid medication, metformin still lowered TSH, but only in those whose TSH was on the higher side of normal to begin with. People with already-low-normal TSH did not see much change.7Oxford Academic. Thyreotropin levels in diabetic patients on metformin treatment The TSH-lowering effect seems most pronounced in people who start with elevated or high-normal TSH levels, which happens to describe many hypothyroid patients.
The practical question this raises is obvious: if metformin is pushing your TSH down, could your levothyroxine dose end up being too high? In theory, yes. If your doctor has titrated your levothyroxine to achieve a TSH of, say, 2.0, and then you start metformin and your TSH drops to 0.8, you may be slightly over-replaced. That is not dangerous in the short term, but sustained over-replacement (a persistently suppressed TSH) can contribute to bone loss and heart rhythm issues over time.
What Is Actually Happening in the Body
Researchers have proposed several ways metformin might lower TSH. It may change the number or sensitivity of thyroid hormone receptors, increase dopamine signaling in the brain (which suppresses TSH release), or directly amplify the effect that thyroid hormones have on the pituitary gland. Metformin may also increase how well levothyroxine is absorbed from the gut, subtly shift the proteins that carry thyroid hormones in the blood, or influence how those hormones are metabolized. The central brain effects likely involve the AMPK energy-sensing pathway: metformin appears to inhibit AMPK in the hypothalamus, which boosts the ability of thyroid hormones to suppress TSH secretion.8PubMed Central. The effect of metformin therapy on serum thyrotropin and free thyroxine concentrations in patients with type 2 diabetes: a meta-analysis
One study specifically tested whether the TSH drop was due to metformin increasing levothyroxine absorption from the gut. After a week of metformin use, researchers measured peak thyroid hormone levels and found no significant difference in how much levothyroxine was absorbed, though there was a slight downward trend in overall exposure.9PubMed Central. Metformin Does Not Suppress Serum Thyrotropin by Increasing Levothyroxine Absorption That suggests the TSH-lowering effect is primarily happening in the brain and pituitary rather than in the gut. Your body is not absorbing more levothyroxine; instead, metformin is making the pituitary more responsive to whatever thyroid hormone is already circulating.
An important detail: this TSH-lowering effect does not appear to happen in people whose thyroid glands are functioning normally.8PubMed Central. The effect of metformin therapy on serum thyrotropin and free thyroxine concentrations in patients with type 2 diabetes: a meta-analysis If your thyroid is healthy and you take metformin for diabetes alone, your TSH is unlikely to budge. The interaction is specific to people who already have thyroid dysfunction or who are on levothyroxine replacement.
Adjusting Your Lab Monitoring
If you are starting metformin while already on a stable levothyroxine dose, or starting levothyroxine while already on metformin, you should expect some movement in your thyroid labs. The standard recommendation for thyroid monitoring is to check TSH about six to eight weeks after any change in levothyroxine dose. That same logic applies when you add, stop, or significantly change your metformin dose, since metformin can shift the TSH independently of any change in levothyroxine.
The tricky scenario is when someone has been on both drugs for years without any issue and then stops metformin, perhaps because of a kidney function change or a switch to a different diabetes medication. The TSH-lowering effect of metformin will disappear, and TSH may rise. If the levothyroxine dose was set while metformin was active, stopping metformin could leave the person under-replaced. Symptoms of creeping hypothyroidism (fatigue, weight gain, cold intolerance) might develop gradually and be blamed on the diabetes medication change rather than recognized as a thyroid issue. Flagging this for your doctor is worthwhile whenever your diabetes regimen changes.
Metformin and Thyroid Nodules
Beyond its effects on TSH, metformin has drawn attention for a separate thyroid-related finding: it may shrink thyroid nodules. In a study of patients with insulin resistance and thyroid nodules, metformin therapy led to a significant reduction in both average thyroid volume and average nodule size.10PubMed Central. Metformin Decreases Thyroid Volume and Nodule Size in Subjects with Insulin Resistance: A Preliminary Study A systematic review pooling data from four studies confirmed a small but statistically significant reduction in thyroid nodule size with metformin treatment.11PubMed. Role of Metformin in the Treatment of Patients with Thyroid Nodules and Insulin Resistance: A Systematic Review and Meta-Analysis The evidence for a reduction in overall thyroid gland volume was weaker and did not reach statistical significance in the meta-analysis.
This is preliminary research, and nobody is prescribing metformin specifically for thyroid nodules. But if you happen to be on metformin for diabetes and you also have thyroid nodules, the finding is reassuring. It suggests metformin is not making thyroid structural issues worse, and it may be helping slightly. The mechanism likely ties back to insulin resistance itself: high insulin levels can stimulate thyroid cell growth, and by improving insulin sensitivity, metformin removes some of that growth signal.
The PCOS Overlap
One population where levothyroxine and metformin frequently overlap is women with polycystic ovary syndrome. PCOS is commonly treated with metformin (for its insulin-sensitizing effects), and hypothyroidism is more prevalent in women with PCOS than in the general population. A study of hypothyroid women with PCOS found that four months of metformin treatment significantly lowered their TSH from a median of 3.2 down to 1.7, without any change in levothyroxine dose.12PubMed. Thyroidal effect of metformin treatment in patients with polycystic ovary syndrome Free T4 levels did not change significantly, echoing what is seen in other populations: the effect is on TSH regulation in the brain, not on the amount of thyroid hormone in the blood.
For women with PCOS managing both conditions, this means the same vigilance applies. Starting metformin may drop TSH enough to warrant a levothyroxine dose reduction, and stopping it may require an increase. Because PCOS management often involves starting and stopping metformin depending on goals like fertility or weight management, thyroid labs should be rechecked after each change.
Hypothyroidism, Insulin Resistance, and Why Both Drugs Matter
People sometimes wonder why they are on both drugs and whether one condition is causing the other. Untreated hypothyroidism is associated with higher insulin levels, elevated cholesterol, and increased triglycerides. In a study of patients who were started on levothyroxine for previously untreated hypothyroidism, fasting insulin levels dropped significantly after treatment, as did total cholesterol, LDL cholesterol, and triglycerides.13PubMed Central. Effects of levothyroxine replacement therapy on insulin resistance in patients with untreated primary hypothyroidism However, actual insulin resistance as measured by standard indices did not change significantly. Getting thyroid levels under control helps your metabolic profile but does not eliminate insulin resistance on its own. That is why metformin often remains necessary even after levothyroxine has normalized thyroid function.
The relationship also runs the other way. Insulin resistance and high insulin levels can promote thyroid cell growth and may worsen thyroid autoimmunity. The two conditions are tangled together metabolically, which is part of why co-prescription of levothyroxine and thyroid replacement therapy in diabetic patients has been rising steadily. Data from a large Spanish primary care database showed a consistent increase in thyroid replacement therapy prescriptions among diabetic individuals between 2018 and 2023, with the highest rates in women aged 65 and older.14American Diabetes Association (Diabetes). 51-PUB: Prescription of Thyroid Hormone Replacement Therapy in Individuals with Diabetes in Spain—Differences by Sex, Age, and Temporal Trends (2018–2023)
Vitamin B12 and Shared Nutritional Risks
One nutritional concern that flies under the radar when taking both drugs is vitamin B12. Metformin is well known to reduce B12 absorption over time, and the risk increases the longer you take it and the higher the dose. Separately, autoimmune thyroid disease (the most common cause of hypothyroidism in developed countries) is independently associated with lower B12 levels. A study comparing patients with autoimmune thyroid disease to controls found significantly lower B12 levels in the thyroid group, with B12 levels inversely correlated to thyroid antibody levels.15Bentham Science Publishers. Correlation Between Vitamin B12 Deficiency and Autoimmune Thyroid Diseases
If you are on both levothyroxine for autoimmune hypothyroidism and metformin for diabetes, you have two independent reasons to be at risk for B12 deficiency. Symptoms of low B12 (fatigue, numbness and tingling in hands and feet, difficulty concentrating) overlap annoyingly with symptoms of both undertreated hypothyroidism and poorly controlled diabetes, which means the deficiency can go unrecognized for a long time. Asking your doctor to check B12 levels periodically, especially if you have been on metformin for more than a year or two, is a simple step that can prevent real neurological harm.
When Doses of Levothyroxine Vary Across the Combination
Levothyroxine dosing in people with both diabetes and hypothyroidism spans a wide range. Observational data from patients managing both conditions has documented levothyroxine doses ranging from 25 mcg all the way up to 125 mcg daily.16Journal of Exploratory Research in Pharmacology. Clinical Evidence of Association Between Type-2 Diabetes Mellitus and Hypothyroidism with Therapeutic Relevance—An Observational Study The right dose for you depends on your body weight, the severity of your hypothyroidism, your residual thyroid function, and now, as the research makes clear, whether you are also on metformin. Someone whose TSH is well-controlled on 75 mcg of levothyroxine before starting metformin might find that same dose pushes their TSH lower than intended once metformin is on board. The adjustment is usually small, but it is real.
The reverse situation also matters. If you have been on both drugs and your doctor increases your metformin dose significantly, check thyroid labs a couple of months later. The TSH-lowering effect appears to scale at least somewhat with metformin exposure, so a dose jump from 500 mg to 2,000 mg daily is worth monitoring for thyroid impact. None of this means the combination is unsafe. It means the two drugs talk to each other metabolically in ways that benefit from periodic attention rather than a set-it-and-forget-it approach.